[Activated protein C, coagulation, inflammation and treatment of severe sepsis].
Ott
A
A
D000893:Anti-Inflammatory Agents / Q000191:economics / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D006801:Humans; D009426:Netherlands; D017009:Professional Autonomy; D011486:Protein C / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins / Q000627:therapeutic use; D012107:Research Design; D012109:Research Support as Topic; D018805:Sepsis / Q000188:drug therapy* / Q000191:economics / Q000378:metabolism
D000893:Anti-Inflammatory Agents; D011486:Protein C; D011994:Recombinant Proteins